163 related articles for article (PubMed ID: 24962328)
1. Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1.
Martino-Echarri E; Fernández-Rodríguez R; Bech-Serra JJ; Plaza-Calonge Mdel C; Vidal N; Casal C; Colomé N; Seoane J; Canals F; Rodríguez-Manzaneque JC
Oncotarget; 2014 Jun; 5(12):4295-304. PubMed ID: 24962328
[TBL] [Abstract][Full Text] [Related]
2. JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration.
Mendes KN; Wang GK; Fuller GN; Zhang W
Int J Oncol; 2010 Jul; 37(1):143-53. PubMed ID: 20514406
[TBL] [Abstract][Full Text] [Related]
3. Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.
Phillips LM; Zhou X; Cogdell DE; Chua CY; Huisinga A; R Hess K; Fuller GN; Zhang W
J Pathol; 2016 Jul; 239(3):355-64. PubMed ID: 27125842
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas.
Rorive S; Berton A; D'haene N; Takacs CN; Debeir O; Decaestecker C; Salmon I
Glia; 2008 Nov; 56(15):1679-90. PubMed ID: 18563800
[TBL] [Abstract][Full Text] [Related]
5. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract][Full Text] [Related]
6. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.
Liu Y; Li F; Yang YT; Xu XD; Chen JS; Chen TL; Chen HJ; Zhu YB; Lin JY; Li Y; Xie XM; Sun XL; Ke YQ
Oncogene; 2019 Mar; 38(11):1815-1831. PubMed ID: 30368528
[TBL] [Abstract][Full Text] [Related]
7. Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma.
Verma BK; Kondaiah P
J Neurooncol; 2020 Sep; 149(2):209-217. PubMed ID: 32803659
[TBL] [Abstract][Full Text] [Related]
8. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.
Zheng S; Houseman EA; Morrison Z; Wrensch MR; Patoka JS; Ramos C; Haas-Kogan DA; McBride S; Marsit CJ; Christensen BC; Nelson HH; Stokoe D; Wiemels JL; Chang SM; Prados MD; Tihan T; Vandenberg SR; Kelsey KT; Berger MS; Wiencke JK
Neuro Oncol; 2011 Mar; 13(3):280-9. PubMed ID: 21339190
[TBL] [Abstract][Full Text] [Related]
9. Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2.
Martino-Echarri E; Fernández-Rodríguez R; Rodríguez-Baena FJ; Barrientos-Durán A; Torres-Collado AX; Plaza-Calonge Mdel C; Amador-Cubero S; Cortés J; Reynolds LE; Hodivala-Dilke KM; Rodríguez-Manzaneque JC
Int J Cancer; 2013 Nov; 133(10):2315-24. PubMed ID: 23681936
[TBL] [Abstract][Full Text] [Related]
10. IGFBP2 promotes glioma tumor stem cell expansion and survival.
Hsieh D; Hsieh A; Stea B; Ellsworth R
Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis.
Sehgal P; Kumar N; Praveen Kumar VR; Patil S; Bhattacharya A; Vijaya Kumar M; Mukherjee G; Kondaiah P
Mol Cancer; 2013 Jun; 12():63. PubMed ID: 23767917
[TBL] [Abstract][Full Text] [Related]
12. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
Liu Y; Song C; Shen F; Zhang J; Song SW
PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network.
Holmes KM; Annala M; Chua CY; Dunlap SM; Liu Y; Hugen N; Moore LM; Cogdell D; Hu L; Nykter M; Hess K; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3475-80. PubMed ID: 22345562
[TBL] [Abstract][Full Text] [Related]
14. IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
Chua CY; Liu Y; Granberg KJ; Hu L; Haapasalo H; Annala MJ; Cogdell DE; Verploegen M; Moore LM; Fuller GN; Nykter M; Cavenee WK; Zhang W
Oncogene; 2016 Feb; 35(6):738-47. PubMed ID: 25893308
[TBL] [Abstract][Full Text] [Related]
15. The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.
Lee CC; Chen PH; Ho KH; Shih CM; Cheng CH; Lin CW; Cheng KT; Liu AJ; Chen KC
PLoS One; 2017; 12(3):e0173890. PubMed ID: 28323865
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS1 Supports Endothelial Plasticity of Glioblastoma Cells with Relevance for Glioma Progression.
Serrano-Garrido O; Peris-Torres C; Redondo-García S; Asenjo HG; Plaza-Calonge MDC; Fernandez-Luna JL; Rodríguez-Manzaneque JC
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396280
[TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth factor binding protein genes and its hypoxic regulation in U87 glioma cells depends on ERN1 mediated signaling pathway of endoplasmic reticulum stress.
Minchenko DO; Kharkova AP; Karbovskyi LL; Minchenko OH
Endocr Regul; 2015 Apr; 49(2):73-83. PubMed ID: 25960008
[TBL] [Abstract][Full Text] [Related]
18. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.
Moore LM; Holmes KM; Smith SM; Wu Y; Tchougounova E; Uhrbom L; Sawaya R; Bruner JM; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16675-9. PubMed ID: 19805356
[TBL] [Abstract][Full Text] [Related]
19. Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion.
Patil SS; Railkar R; Swain M; Atreya HS; Dighe RR; Kondaiah P
J Neurooncol; 2015 Jun; 123(2):225-35. PubMed ID: 25944386
[TBL] [Abstract][Full Text] [Related]
20. The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways.
Tan Ide A; Ricciardelli C; Russell DL
Int J Cancer; 2013 Nov; 133(10):2263-76. PubMed ID: 23444028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]